Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy

NCT02863354 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Proliferative Diabetic Retinopathy

Interventions

DRUG: Aflibercept

Sponsor

Charles C Wykoff, PhD, MD

Collaborators

[object Object]